AnGes: AG0302-COVID19

AnGes: AG0302-COVID19

Vaccine Type: DNA

About Trial Phases

Phase 1: 1 Trial

NCT04527081
Japan

Phase 2: 2 Trials

NCT04655625
Japan
NCT04527081
Japan

Phase 3: 1 Trial

NCT04655625
Japan

Approvals: 0 Approvals

This vaccine is not yet approved.

Registered Trials

NCT04655625
Phase 2/3
Japan
Total Enrollment: 500
Official Trial Registration:
- NCT04655625(Opens in new tab/window)
NCT04527081
Phase 1/2
Japan
Total Enrollment: 30
Official Trial Registration:
- NCT04527081(Opens in new tab/window)

© 2021 McGill COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form